⁦VEX Robotics⁩ ⁦Westminster⁩ go team 6199E, eliminations at 12:45 PM

⁦Winship Cancer Institute of Emory University⁩ ⁦Sagar Lonial MD⁩ ⁦Jonathan Kaufman, MD⁩ the honor to have a drink from that king glass at Sagar home happens when you hit an important career mile stone. Congratulations my friend - you are an associate professor

Shrinking the divide: improving myeloma CART access ⁦Sagar Lonial MD⁩ ⁦Winship Cancer Institute of Emory University⁩ ⁦International Myeloma Foundation⁩ ⁦⁦Multiple Myeloma RF⁩ ⁦Krina Patel⁩ - Peres et al provides the real world evidence of CART In minorities pubmed.ncbi.nlm.nih.gov/38194242/

🆕 #MMUpdate series

1️⃣ evt.to/asiuhohaw
💬 CARTITUDE-2 Trial Updated Results
👥 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰, Joshua Richter, MD, FACP, & Ajay Nooka, MD, MPH

2️⃣ evt.to/asiuhhshw
💬 PERSEUS Trial Insights from ASH
👥 C. Ola Landgren, M.D., Joshua Richter, MD, FACP, & Ajay Nooka, MD, MPH

Martin our group and others have been treating them differently in the maintenance phase for over a decade.

New study led by Ajay Nooka, MD, MPH & available #OpenAccess | Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory #MultipleMyeloma in the MajesTEC-1 study

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

#MMSM
OncoAlert

New and #OpenAccess | Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in #MultipleMyeloma .

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

@oncoalert Ajay Nooka, MD, MPH #MMSM

⁦Sagar Lonial MD⁩ ⁦Vincent Rajkumar⁩ fireside chat with Sid Mukherkee, one of my fav authors

⁦Aaron Goodman - “Papa Heme”⁩ ⁦Vincent Rajkumar⁩ ⁦chadi nabhan MD, MBA, FACP⁩ ⁦Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽⁩ ASCO has reached out to members with this survey. No one denies the value of initial certification but I question the value of MOC; took me 3 minutes - be aware some questions are double negatives

⁦International Myeloma Foundation⁩ ⁦Winship Cancer Institute of Emory University⁩ ⁦Joseph Mikhael⁩ ⁦Sagar Lonial MD⁩ Charise Gleason emphasizing supportive measures for myeloma patients at IMF Atlanta Regional Community Workshop - a packed room

Meet Robert Z. Orlowski, Biran Noam & I at #ASCO23 on 6/3 at 6:30 PM CDT and get guidance on upfront and sequential therapy selection with the latest #Antibody and #Immunotherapy platforms for #MultipleMyeloma . bit.ly/3nQJVSc @HealthtreeMM PeerView

This Sankey plot says it all - very timely to allow for understanding and clinical decision making for CRS management with teclistamab

Friday at #ASH22 ! Join Ajai Chari Ajay Nooka, MD, MPH Krina Patel for #myeloma case-based roundtable discussing practical challenges & evidence-based approaches to #MMsm // ✅Avoid FOMO ✅Earn #CME ⏰Register ms.spr.ly/6016dS5Tr 11:30am Hyatt or virtual Medscape Education MedscapeLIVE

Come join the best APP team, the smartest and brightest!!

1 in 3 people respond and the responses are beyond a year for a drug given every 3 weeks. Downside: corneal toxicity, but reversible

🤔 Do you have questions on off-the-shelf BCMA-targeted treatment in RRMM?

🗣️ Sagar Lonial MD, C. Ola Landgren, M.D., & Ajay Nooka, MD, MPH will answer all of your questions in a #CME Clinical Brief!

Join us TONIGHT on Integrity CE SoMe CME @ 6:30 PM EDT
#MMBrief #mutiplemyeloma #mmsm

On my way to #IMS2022 , so looking forward to hearing about the new #mmsm advances, the scientific content looks fantastic! Several Myeloma Society members will be facilitating Twitter Spaces chats about each session with the presenters! Stay tuned! Shaji Kumar Sagar Lonial MD

Calling all #mmsm peeps, please click the link below and register (live or virtual) for the #IMS2022 ! Previously known as the IMW that was held every 2 years, the IMS Meeting will be an Annual event. Hem-Onc Fellows Network Mohamad Mohty Graham jackson Anita D'Souza Surbhi Sidana, MD

Join our vibrant team at Emory

A day to honor the country turns into another sad day. The world is aghast wondering what kind of freedom we have.